Direkt zum Inhalt
Merck
  • Hyperosmolarity induced by high glucose promotes senescence in human glomerular mesangial cells.

Hyperosmolarity induced by high glucose promotes senescence in human glomerular mesangial cells.

The international journal of biochemistry & cell biology (2014-07-22)
Maria del Nogal, Nuria Troyano, Laura Calleros, Mercedes Griera, Manuel Rodriguez-Puyol, Diego Rodriguez-Puyol, María P Ruiz-Torres
ZUSAMMENFASSUNG

Hyperglycemia is involved in the diabetic complication of different organs and can elevate serum osmolarity. Here, we tested whether hyperosmolarity promoted by high glucose levels induces cellular senescence in renal cells. We treated Wistar rats with streptozotocin to induce diabetes or with consecutive daily injections of mannitol to increase serum osmolarity and analyzed p53 and p16 genes in renal cortex by immunohistochemistry. Both diabetic and mannitol treated rats showed a significant increase in serum osmolarity, without significant signs of renal dysfunction, but associated with increased staining for p53 and p16 in the renal cortex. An increase in p53 and p16 expression was also found in renal cortex slices and glomeruli isolated from healthy rats, which were later treated with 30 mM glucose or mannitol. Intracellular mechanisms involved were analyzed in cultured human glomerular mesangial cells treated with 30 mM glucose or mannitol. After treatments, cells showed increased p53, p21 and p16 expression and elevated senescence-associated β-galactosidase activity. Senescence was prevented when myo-inositol was added before treatment. High glucose or mannitol induced constitutive activation of Ras and ERK pathways which, in turn, were activated by oxidative stress. In summary, hyperosmolarity induced renal senescence, particularly in glomerular mesangial cells, increasing oxidative stress, which constitutively activated Ras-ERK 1/2 pathway. Cellular senescence could contribute to the organ dysfunction associated with diabetes.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Streptozocin, ≥75% α-anomer basis, ≥98% (HPLC), powder
Sigma-Aldrich
D-Mannitol, ≥98% (GC)
Sigma-Aldrich
myo-Inositol, ≥99% (GC), BioReagent
Sigma-Aldrich
myo-Inositol, ≥99%
Supelco
D-Mannitol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
D-Mannitol, ACS reagent
Sigma-Aldrich
D-Mannitol, ≥98% (GC), suitable for plant cell culture
Sigma-Aldrich
Hämatoxylin
USP
Mannitol, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Hämatoxylin, certified by the BSC
Sigma-Aldrich
D-Mannitol, BioUltra, ≥99.0% (sum of enantiomers, HPLC)
Sigma-Aldrich
D-Mannitol, meets EP, FCC, USP testing specifications
Sigma-Aldrich
D-Mannitol, BioXtra, ≥98% (HPLC)
Mannitol, European Pharmacopoeia (EP) Reference Standard
Millipore
myo-Inositol, ≥99.0%, suitable for microbiology
Millipore
D-Mannitol, ACS reagent, suitable for microbiology, ≥99.0%
Sigma-Aldrich
DL-Cystein, technical grade
Sigma-Aldrich
PD 98,059, solid
Sigma-Aldrich
D-Mannitol, tested according to Ph. Eur.
Supelco
D-Mannitol, ≥99.9999% (metals basis), for boron determination
myo-Inositol, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
p53 human, recombinant, expressed in E. coli, buffered aqueous glycerol solution
Sigma-Aldrich
p53 human, recombinant, expressed in baculovirus infected Sf21 cells
Sigma-Aldrich
MISSION® esiRNA, targeting human KRAS
Sigma-Aldrich
MISSION® esiRNA, targeting human TP53
Sigma-Aldrich
MISSION® esiRNA, targeting human TPT1